- CFO Spotlights
- Profiles
- Erik Ellingson
Profile
Erik Ellingson
Chief Financial Officer, HeartSciences Inc.
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Erik Ellingson has been Chief Financial Officer of HeartSciences Inc. since not stated, according to the company's filing of June 26, 2026.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| HeartSciences Inc. (HSCS) Finance Services | Chief Financial Officer | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- Date not statedfiled June 26, 2026
HeartSciences Inc. appointed Erik Ellingson as Chief Financial Officer, with an effective date the filing does not state. Profile of Danielle Watson.
Ellingson to be appointed as the new Chief Financial Officer of HeartSciences to replace Ms.
[1] Filing by HeartSciences Inc., filed with the SEC on June 26, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Current report filed with the SEC, HeartSciences Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 26, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Erik Ellingson wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.